Literature DB >> 10878389

Differential expression of CC chemokines and the CCR5 receptor in the pancreas is associated with progression to type I diabetes.

M J Cameron1, G A Arreaza, M Grattan, C Meagher, S Sharif, M D Burdick, R M Strieter, D N Cook, T L Delovitch.   

Abstract

We investigated the biological role of CC chemokines in the Th1-mediated pathogenesis of spontaneous type I diabetes in nonobese diabetic (NOD) mice. Whereas an elevated ratio of macrophage inflammatory protein-1alpha (MIP-1alpha):MIP-1beta in the pancreas correlated with destructive insulitis and progression to diabetes in NOD mice, a decreased intrapancreatic MIP-1alpha:MIP-1beta ratio was observed in nonobese diabetes-resistant (NOR) mice. IL-4 treatment, which prevents diabetes in NOD mice by polarizing intraislet Th2 responses, decreased CCR5 expression in islets and potentiated a high ratio of MIP-1beta and monocyte chemotactic protein-1 (MCP-1): MIP-1alpha in the pancreas. Furthermore, NOD.MIP-1alpha-/- mice exhibited reduced destructive insulitis and were protected from diabetes. Neutralization of MIP-1alpha with specific Abs following transfer of diabetogenic T cells delayed the onset of diabetes in NOD.Scid recipients. These studies illustrate that the temporal expression of certain CC chemokines, particularly MIP-1alpha, and the CCR5 chemokine receptor in the pancreas is associated with the development of insulitis and spontaneous type I diabetes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10878389     DOI: 10.4049/jimmunol.165.2.1102

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  Fatal attraction: chemokines and type 1 diabetes.

Authors:  Mark A Atkinson; S Brian Wilson
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

2.  Adenosine receptor activation ameliorates type 1 diabetes.

Authors:  Zoltán H Németh; David Bleich; Balázs Csóka; Pál Pacher; Jon G Mabley; Leonóra Himer; E Sylvester Vizi; Edwin A Deitch; Csaba Szabó; Bruce N Cronstein; György Haskó
Journal:  FASEB J       Date:  2007-04-03       Impact factor: 5.191

3.  Homing of human autoreactive T cells into pancreatic tissue of NOD-scid mice.

Authors:  A G S van Halteren; M J Kardol; A Mulder; B O Roep
Journal:  Diabetologia       Date:  2004-12-24       Impact factor: 10.122

4.  Gene therapy in diabetes.

Authors:  Mary S Wong; Wayne J Hawthorne; Nicholas Manolios
Journal:  Self Nonself       Date:  2010-06-09

Review 5.  Immune cell trafficking to the islets during type 1 diabetes.

Authors:  A M Sandor; J Jacobelli; R S Friedman
Journal:  Clin Exp Immunol       Date:  2019-08-30       Impact factor: 4.330

6.  Immunohistochemical study of monocyte chemoattractant protein-1 in the pancreas of NOD mice following cyclophosphamide administration and during spontaneous diabetes.

Authors:  Yan Bai; Elizabeth Robinson; Ryan Chai; Jacqueline M Ross; Shiva Reddy
Journal:  J Mol Histol       Date:  2006-07-29       Impact factor: 2.611

7.  The novel inosine analogue, INO-2002, protects against diabetes development in multiple low-dose streptozotocin and non-obese diabetic mouse models of type I diabetes.

Authors:  Jon G Mabley; Pal Pacher; Kanneganti G K Murthy; William Williams; Garry J Southan; Andrew L Salzman; Csaba Szabo
Journal:  J Endocrinol       Date:  2008-06-18       Impact factor: 4.286

8.  Regulating MCP-1 diffusion in affinity hydrogels for enhancing immuno-isolation.

Authors:  Chien-Chi Lin; Patrick D Boyer; Alex A Aimetti; Kristi S Anseth
Journal:  J Control Release       Date:  2009-11-29       Impact factor: 9.776

9.  Inosine protects against the development of diabetes in multiple-low-dose streptozotocin and nonobese diabetic mouse models of type 1 diabetes.

Authors:  Jon G Mabley; Alex Rabinovitch; Wilma Suarez-Pinzon; György Haskó; Pál Pacher; Robert Power; Gary Southan; Andrew Salzman; Csaba Szabó
Journal:  Mol Med       Date:  2003 Mar-Apr       Impact factor: 6.354

Review 10.  The role of inflammation in insulitis and beta-cell loss in type 1 diabetes.

Authors:  Décio L Eizirik; Maikel L Colli; Fernanda Ortis
Journal:  Nat Rev Endocrinol       Date:  2009-04       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.